Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroleptic malignant syndrome

M F Bristow1, D Kohen

  • 1Cheam Resource Centre, St Helier Trust University Hospital, Surrey.

British Journal of Hospital Medicine
|April 17, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intentional injury hospitalizations in geographical areas with a high percentage of Aboriginal-identity residents, 2004/2005 to 2009/2010.

Chronic diseases and injuries in Canada·2014
Same author

Posterior fossa tumours presenting to psychiatrists.

Behavioural neurology·2014
Same author

Neighbourhood income gradients in hospitalisations due to motor vehicle traffic incidents among Canadian children.

Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention·2009
Same author

Launch of the Cardiac Safety in Schizophrenia Group (CSISG).

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry·2003
Same author

Transitions on and off AFDC: implications for parenting and children's cognitive development.

Child development·2001
Same author

Genetic association studies of schizophrenia using the 8p21-22 genes: prepronociceptin (PNOC), neuronal nicotinic cholinergic receptor alpha polypeptide 2 (CHRNA2) and arylamine N-acetyltransferase 1 (NAT1).

European journal of human genetics : EJHG·2001
Same journal

The autopsy in the 1990s.

British journal of hospital medicine·1999
Same journal

Screening for breast cancer.

British journal of hospital medicine·1999
Same journal

Cost-effective monotherapy of concomitant benign prostatic hyperplasia and hypertension.

British journal of hospital medicine·1999
Same journal

Liposarcoma: a review of current diagnosis and management.

British journal of hospital medicine·1999
Same journal

How to do it in surgery: laparoscopic rectopexy.

British journal of hospital medicine·1999
Same journal

The management of ovarian cancer.

British journal of hospital medicine·1999
See all related articles

Neuroleptic malignant syndrome (NMS) is a rare, potentially fatal reaction to neuroleptic medications. Early recognition, understanding risk factors, and prompt treatment are crucial for managing this condition.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Clinical Medicine

Background:

  • Neuroleptic malignant syndrome (NMS) is a rare but severe adverse reaction to neuroleptic medications.
  • It can occur at any point during neuroleptic treatment and carries a significant mortality risk.
  • While most common in psychiatric patients, NMS can affect any individual receiving neuroleptic drugs and has been linked to other agents.

Purpose of the Study:

  • To provide a comprehensive overview of neuroleptic malignant syndrome.
  • To discuss the recognition, risk factors, clinical presentation, and management strategies for NMS.
  • To summarize current etiological theories regarding NMS.

Main Methods:

  • Literature review and synthesis of existing research on NMS.

Related Experiment Videos

  • Analysis of clinical case reports and epidemiological data.
  • Discussion of pharmacological and clinical aspects of NMS.

    • Main Results:

    • NMS is an idiosyncratic reaction, not strictly dose-dependent.
    • Key features include hyperthermia, muscle rigidity, autonomic instability, and altered mental status.
    • Risk factors include type of neuroleptic, route of administration, and patient susceptibility.

    Conclusions:

    • Prompt diagnosis and intervention, including discontinuation of the offending agent and supportive care, are vital.
    • While the exact cause remains unclear, current theories involve dopaminergic blockade.
    • Further research into predictive factors and novel treatments is warranted.